CH-6370 Stans - Switzerland
T +41 (0)840 200 010
F +41 (0)840 200 011
mondoBIOTECH holding AG (SIX: RARE) announces that it has signed an investment agreement with the alternative investment firm, The Global Emerging Markets Group (GEM), whose funds will invest up to CHF 11 million into the Company over the next three years.
mondoBIOTECH holding AG (SIX: RARE) announces today to have been granted the patent for the method of treatment of Hepatitis B virus infection by the United States Patent Office, for its medicinal product candidate DasKloster 0039.